 Carcinoma uterus use gadopentetate dimeglumine MR imaging prospective study role gadopentetate dimeglumine-enhanced magnetic resonance imaging detection staging carcinomas endometrium cervix Surgical-pathologic findings standard reference evaluation endometrial carcinoma contrast-enhanced imaging improved tumor detection differentiation viable tumor debris Use contrast material staging accuracy ability depth myometrial invasion evaluation cervical carcinoma assessment tumor location size contrast enhancement Use gadopentetate dimeglumine overestimation stromal parametrial vaginal and/or bladder wall invasion patients evaluation intratumoral architecture large lesions contrast-enhanced imaging stage II disease use contrast material evaluation disease extent authors gadolinium enhancement accuracy evaluation endometrial carcinoma useful advanced cases cervical carcinoma